Vaccine News and Research

Latest Vaccine News and Research

In his continued sparring with Fauci, Sen. Rand Paul oversimplified the science

That Sen. Rand Paul of Kentucky often disagrees with infectious-disease expert Dr. Anthony Fauci is well known.

29 Mar 2021

Addressing the increasing plasticity of SARS-CoV-2

Researchers summarize what this rapid increase of plasticity of SARS-CoV-2 could mean for the future of the pandemic and anti-SARS-CoV-2 measures.

29 Mar 2021

Single Sputnik V vaccine dose elicits robust immune response in previously infected individuals

A new preprint research paper posted to the medRxiv server describes successful immunization of the vaccinated population with a single dose of the Russian-made Sputnik V vaccine.

29 Mar 2021

Antibody agents effective at neutralizing European, South African, and United States SARS-CoV-2 variants

Researchers in the United States have demonstrated the effectiveness of three antibody agents at neutralizing recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic.

28 Mar 2021

mRNA vaccines and monoclonal antibodies protect against new NYC-B.1.526 variant

A new fast-spreading severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant called B.1.526 recently emerged in New York City and caused concerns for its potential to resist the immune system.

28 Mar 2021

Universal mask policy could reduce healthcare workers' risk of acquiring COVID-19

A study published in the Journal of Occupational and Environmental Medicine from researchers at Henry Ford Health System has found that Henry Ford's early implementation of a universal mask policy in the COVID-19 pandemic was associated with reducing the risk of healthcare workers at Henry Ford acquiring COVID-19.

26 Mar 2021

UTEP helps streamline the process at COVID-19 vaccination clinics in the U.S.

Sreenath Chalil Madathil, Ph.D., assistant professor in industrial manufacturing and systems engineering (IMSE) at The University of Texas at El Paso, is working to streamline the process and ease the patient experience at COVID-19 vaccination clinics in the United States to ensure faster vaccine distribution.

26 Mar 2021

New project receives $9 million CIHR funding to track global threat of COVID-19 variants

A project spearheaded by a researcher at the University of Ottawa's Faculty of Medicine has been awarded $9 million in Canadian Institutes of Health Research (CIHR) funding to create a national network for better researching and responding to the global threat COVID-19 variants pose.

26 Mar 2021

A novel approach to oral vaccination against Covid-19

Scientists at the University of Würzburg together with a pharmaceutical company are working on a novel approach to oral vaccination against the coronavirus.

26 Mar 2021

Longitudinal study of SARS-CoV-2 antibodies following vaccination

A longitudinal study of IgG antibody levels in vaccinated healthcare workers was recently uploaded to the preprint server medRxiv*, suggesting that IgG levels could be a reliable indicator of successful vaccination.

26 Mar 2021

High-fiber diet can significantly alter the gut microbiome and nutrient intake

A short-term intervention in daily fiber consumption can significantly alter the gut microbiome and nutrient intake, according to a study led by University of California, Irvine researchers. The research was recently published by the American Society for Microbiology.

26 Mar 2021

How one state’s public health defunding led to vaccination chaos

Missourians have driven hours to find vaccines in rural counties — at least those with cars and the time. Tens of thousands of doses are waiting to be distributed, slowly being rolled out in a federal long-term care program.

26 Mar 2021

One dose of Pfizer vaccine generates strong immune response against COVID-19

A new study led by the Universities of Sheffield and Oxford with support from the UK Coronavirus Immunology Consortium (UK-CIC) has found that 99 per cent of people generate a robust immune response against Covid-19 after just one dose of the Pfizer vaccine.

26 Mar 2021

Genomic sieve analysis can inform the development of SARS-Cov-2 vaccine

As concern has grown over COVID-19 variants and their implications for how well COVID-19 vaccines will protect against the virus, researchers have proposed a method to examine instances of SARS-COV-2 infections in people who have received a COVID-19 vaccine.

26 Mar 2021

Study: COVID-19 vaccines may remain effective against new influenza viruses

Influenza vaccines need to be evaluated every year to ensure they remain effective against new influenza viruses.

26 Mar 2021

Vaccine hesitancy could pose a major threat to public health efforts to end COVID-19

Although demand for COVID-19 vaccines currently seems high, vaccine hesitancy could pose a major threat to public health efforts to end the pandemic, according to an editorial published today in the journal Science.

25 Mar 2021

KHN’s ‘What the Health?’: Getting down to work at HHS

As questions swirl about the Covid vaccine made by AstraZeneca, public health experts are worried the confusion could create more doubts among people already hesitant to get a vaccine.

25 Mar 2021

Stop blaming Tuskegee, critics say. It’s not an ‘excuse’ for current medical racism.

For months, journalists, politicians and health officials — including New York Gov. Andrew Cuomo and Dr. Anthony Fauci — have invoked the infamous Tuskegee syphilis study to explain why Black Americans are more hesitant than white Americans to get the coronavirus vaccine.

25 Mar 2021

Inmates’ distrust of prison health care fuels distrust of Covid vaccines

One November night in a Missouri prison, Charles Graham woke his cellmate of more than a dozen years, Frank Flanders, saying he couldn't breathe. Flanders pressed the call button. No one answered, so he kicked the door until a guard came.

25 Mar 2021

Dual-antigen COVID-19 vaccine elicits humoral and cellular immune responses in mice

The scientific consensus is that safe and highly effective vaccines are required to end the ongoing pandemic of coronavirus disease 2019 COVID-19, caused by SARS-CoV-2. A new study describes a new vaccine that presents two viral antigens to the human immune system, in order to elicit a more efficacious response.

25 Mar 2021

Vaccine News and Research

Latest Vaccine News and Research

In his continued sparring with Fauci, Sen. Rand Paul oversimplified the science

Addressing the increasing plasticity of SARS-CoV-2

Single Sputnik V vaccine dose elicits robust immune response in previously infected individuals

Antibody agents effective at neutralizing European, South African, and United States SARS-CoV-2 variants

mRNA vaccines and monoclonal antibodies protect against new NYC-B.1.526 variant

Universal mask policy could reduce healthcare workers' risk of acquiring COVID-19

UTEP helps streamline the process at COVID-19 vaccination clinics in the U.S.

New project receives $9 million CIHR funding to track global threat of COVID-19 variants

A novel approach to oral vaccination against Covid-19

Longitudinal study of SARS-CoV-2 antibodies following vaccination

High-fiber diet can significantly alter the gut microbiome and nutrient intake

How one state’s public health defunding led to vaccination chaos

One dose of Pfizer vaccine generates strong immune response against COVID-19

Genomic sieve analysis can inform the development of SARS-Cov-2 vaccine

Study: COVID-19 vaccines may remain effective against new influenza viruses

Vaccine hesitancy could pose a major threat to public health efforts to end COVID-19

KHN’s ‘What the Health?’: Getting down to work at HHS

Stop blaming Tuskegee, critics say. It’s not an ‘excuse’ for current medical racism.

Inmates’ distrust of prison health care fuels distrust of Covid vaccines

Dual-antigen COVID-19 vaccine elicits humoral and cellular immune responses in mice

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in